From 15th to 18th of May, our CEO and CMO will be attending various international events in Hong Kong introducing the latest advances of our company. They will attend Asia Summit on Global Health, Invest in Honk Kong #investHK, and different meeting with local business Angels.
April 20th. We are going to attend the 19th Annual Anglonordic Life Science Conference.
Meet us to discuss face to face about our latest works: CA04 first-in-class monoclonal antibody, CA05 first-in-class kinase inhibitor and CA07 novel PROTAC.
We can’t wait to hear from you.
CancerAppy was present at Anglonordic 2022. An event in which we had the opportunity to contact investors and companies in the biotechnology sector and present our research projects.
We are going to stay in Tel Aviv from March 25th through March 28th looking to learn about entrepreneurship, new relationships and visiting investors.
CancerAppy SL en el marco del Programa ICEX Next, ha
contado con el apoyo de ICEX y con la cofinanciación del fondo europeo FEDER. La finalidad de este apoyo es contribuir al desarrollo internacional de la empresa y de su entorno.
We once again attend the B-venture 2021 event in Bilbao this time under the sponsorship of DeustoEmprende.